Featured · Drug Pricing
The Taxpayers Protection Alliance’s Ross Marchand Discusses FDA Drug Approval Challenges and Solutions
In the Health Policy Podcast episode featuring Ross Marchand, Executive Director of the Taxpayers Protection Alliance, the discussion centers on the challenges and inefficiencies of the FDA drug approval process. Marchand highlights a report titled "Blocking Breakthroughs," which reveals increasing rejection rates for medications and rising evaluation costs, emphasizing the need for regulatory reforms to improve patient access to life-saving drugs. Recommendations include regulatory reciprocity with international agencies and provisional approvals for medications that meet safety but not efficacy thresholds.
2026-05-05 · with Ross Marchand
